Working… Menu

Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01701856
Recruitment Status : Terminated (Problems to recruit the needed number of patients in the planned time)
First Posted : October 5, 2012
Last Update Posted : January 22, 2014
Information provided by (Responsible Party):
Claudio Gobbi, Ospedale Civico, Lugano

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : October 2013
Actual Study Completion Date : October 2013